The tRNA-Cys-GCA Derived tsRNAs Suppress Tumor Progression of Gliomas via Regulating VAV2
Open Access
- 15 November 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-16
Abstract
The tsRNAs (tRNA-derived small RNAs) are new types of small noncoding RNAs derived from tRNAs. Gliomas are well-known malignant brain tumors. The study focused on tsRNA characterizations within gliomas. Datasets processing, bioinformatics analyses, and visualizations were performed with the packages of Python and R. Cell proliferations were demonstrated via CCK8 assays and colony formation assays, and in vivo xenograft experiments. Dual-luciferase reporter assay was performed to confirm the binding of tsRNA with its targets. Via using bioinformatics approaches, the hundreds of tsRNAs with available expression abundance were identified in gliomas dataset, most of them derived from D-loop or T-loop fragments of tRNAs. Among tsRNAs derived from tRNA-Cys-GCA, tRFdb-3003a and tRFdb-3003b (tRFdb-3003a/b) were remarkably down-regulated in gliomas. The survival outcome of gliomas patients with low tRFdb-3003a/b expressions was notably worse than that of high-expression patients. In glioma cells, tRFdb-3003a could suppress cells proliferation and colony formation ability. In vivo, tRFdb-3003a suppressed the tumor growth of xenograft gliomas. Enrichment analyses displayed the tRFdb-3003a-related mRNAs were enriched in the specific GO terms, spliceosome and autophagy pathways, and three GSEA molecular signatures. Mechanically, 3-UTR regions of VAV2 mRNA were predicted to contain the binding positions of tRFdb-3003a/b, tRFdb-3003a and tRFdb-3003b was effective to reduce the relative luciferase activity of cells with VAV2 wild-type reporter. Overexpression of tRFdb-3003a/b could down-regulated the expression levels of VAV2 protein and mRNA in glioma cells. The tRNA-Cys-GCA derived tRFdb-3003a and tRFdb-3003b might act as key player in tumor progressions of gliomas; tRFdb-3003a/b might directly bind to VAV2 and regulate VAV2 expressions in gliomas.Keywords
Funding Information
- Chongqing Education Commission of China (KJQN202200430, cstc2021jcyj-msxmX0302, 82003854)
- Project of Science and Technology Research Program (KJQN202200430, cstc2021jcyj-msxmX0302, 82003854)
- Natural Science Foundation of Chongqing Municipality (KJQN202200430, cstc2021jcyj-msxmX0302, 82003854)
- National Natural Science Foundation of China (KJQN202200430, cstc2021jcyj-msxmX0302, 82003854)
This publication has 31 references indexed in Scilit:
- Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer typesNucleic Acids Research, 2017
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Insulator dysfunction and oncogene activation in IDH mutant gliomasNature, 2015
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA dataNucleic Acids Research, 2015
- GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomesNucleic Acids Research, 2015
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- tRFdb: a database for transfer RNA fragmentsNucleic Acids Research, 2014
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009